Psychiatric Reactions and Behavioral Changes
Mydriacyl may occasionally cause changes in behavior, mood, or mental alertness because of its anticholinergic effects.
It contains tropicamide, a medication that temporarily blocks the action of acetylcholine, a chemical messenger involved in several functions of the nervous system.
Although Mydriacyl is applied directly to the eyes, a small amount of the medication may enter the bloodstream and affect other parts of the body.
In rare cases, patients may experience confusion, agitation, unusual behavior, hallucinations, or other psychiatric symptoms.
These reactions are more likely to occur in individuals who are particularly sensitive to anticholinergic medications, including some children and older adults.
A psychotic reaction may cause a person to see or hear things that are not present or experience a temporary loss of contact with reality.
To reduce medication absorption, your healthcare provider may recommend gently pressing the inner corner of the eye near the nose after administering the drops.
Seek immediate medical attention if you experience severe confusion, hallucinations, extreme agitation, or significant behavioral changes after using Mydriacyl.
Angle-Closure Glaucoma
Mydriacyl should be used with particular caution in patients who have narrow drainage angles in their eyes or a history of angle-closure glaucoma.
Glaucoma is a group of eye conditions that can damage the optic nerve, often because of increased pressure inside the eye.
The optic nerve carries visual information from the eyes to the brain.
Mydriacyl temporarily enlarges the pupils, allowing an eye care professional to examine the internal structures of the eye.
However, pupil dilation may narrow or block the normal drainage pathway for fluid inside the eye in susceptible patients.
When fluid cannot drain properly, pressure inside the eye may rise suddenly.
This can cause acute angle-closure glaucoma, a medical emergency that may result in permanent vision damage if not treated promptly.
Symptoms may include severe eye pain, blurred vision, headache, nausea, vomiting, and seeing colored halos around lights.
Your eye care professional should assess your risk before administering pupil-dilating medications.
Mydriacyl should not be used in patients with known or suspected narrow-angle glaucoma when contraindicated by the applicable product labeling.
Seek emergency medical attention if you experience severe eye pain, sudden vision changes, or other symptoms of acute angle-closure glaucoma.
Blurred Vision and Sensitivity to Light
Mydriacyl commonly causes temporary blurred vision and increased sensitivity to bright light.
These effects occur because the medication enlarges the pupils and temporarily relaxes the muscles responsible for focusing.
Normally, the pupils become smaller in bright environments to reduce the amount of light entering the eyes.
After Mydriacyl is administered, the pupils remain enlarged for several hours.
This allows more light to enter, which may cause discomfort when exposed to sunlight or bright indoor lighting.
The medication may also make it difficult to focus on nearby objects, such as books, mobile phones, or computer screens.
Most patients experience improvement as the medication wears off, although the duration varies.
Wearing sunglasses may help reduce light sensitivity.
Do not drive, operate heavy machinery, or perform activities requiring clear vision until the effects of Mydriacyl have completely worn off.
Contact Lens Precautions
Remove your contact lenses before using Mydriacyl eye drops.
Some Mydriacyl formulations contain preservatives, such as benzalkonium chloride, that may be absorbed by soft contact lenses.
These preservatives can cause irritation or affect the lenses.
Contact lenses may also interfere with proper eye drop application.
After receiving Mydriacyl, your eyes may remain sensitive to light or experience temporary blurred vision.
Ask your healthcare provider when it is safe to reinsert your contact lenses.
Do not put your lenses back in if your eyes remain red, irritated, or uncomfortable.
Always remove contact lenses before using Mydriacyl and follow your eye care professional’s instructions about when to wear them again.
Allergic Reactions to Mydriacyl
Do not use Mydriacyl if you are allergic to tropicamide or any other ingredient in the ophthalmic solution.
An allergic reaction occurs when the immune system responds to a substance it mistakenly identifies as harmful.
Some patients may experience mild reactions, including eye redness, itching, swelling, or irritation.
These symptoms may occur shortly after the drops are administered.
However, persistent or worsening irritation may indicate sensitivity to the medication or its ingredients.
In rare cases, a more serious allergic reaction may occur.
Symptoms may include swelling of the face, lips, tongue, or throat, difficulty breathing, or difficulty swallowing.
Tell your healthcare provider if you have experienced an allergic reaction to Mydriacyl or other eye medications in the past.
Do not use Mydriacyl if you have a known allergy to tropicamide or any component of the formulation.
Seek emergency medical attention if you develop difficulty breathing, significant facial swelling, or other symptoms of a severe allergic reaction.
Central Nervous System Effects in Patients With Neurological Conditions
Mydriacyl should be used with additional caution in patients with certain neurological or developmental conditions.
These may include Down syndrome, cerebral palsy associated with spasticity, or brain injuries.
Some individuals with these conditions may be more sensitive to the effects of anticholinergic medications.
Although Mydriacyl is administered directly into the eyes, a small amount of the medication may enter the bloodstream.
In susceptible patients, this may affect the central nervous system, which includes the brain and spinal cord.
Possible symptoms include unusual agitation, confusion, changes in behavior, or other neurological disturbances.
Children may be particularly vulnerable to these effects.
Your healthcare provider may take additional precautions, including selecting an appropriate dosage and reducing medication drainage through the tear ducts.
Tell your healthcare provider if you or your child has Down syndrome, cerebral palsy, a history of brain injury, or another neurological condition before receiving Mydriacyl.
Increased Eye Pressure (Intraocular Pressure)
Mydriacyl may temporarily increase pressure inside the eye.
This pressure is called intraocular pressure (IOP).
The eye normally maintains a stable pressure by balancing the production and drainage of fluid.
Mydriacyl temporarily enlarges the pupil, which can affect fluid drainage in susceptible individuals.
Patients with narrow drainage angles may be at risk of developing a sudden and potentially dangerous increase in eye pressure.
People with existing glaucoma or a history of elevated intraocular pressure should inform their eye care professional before treatment.
Your healthcare provider may assess your eye pressure and the structure of the drainage angle before administering Mydriacyl.
However, not every type of glaucoma carries the same risk.
Patients with well-controlled open-angle glaucoma may sometimes receive pupil-dilating drops under appropriate supervision.
Tell your eye care professional if you have glaucoma, elevated eye pressure, or a history of angle-closure glaucoma before using Mydriacyl.
Seek emergency medical attention if you develop severe eye pain, sudden blurred vision, headache with nausea, or halos around lights.
Cardiovascular Disease and Heart-Related Side Effects
Patients with cardiovascular disease should inform their healthcare provider before receiving Mydriacyl.
Although the medication is applied directly to the eyes, some tropicamide may be absorbed into the bloodstream.
In rare cases, this may cause effects outside the eyes, including changes in heart rate.
One possible reaction is tachycardia, which means an unusually fast heartbeat.
Some patients may also experience dizziness, flushing, or changes in blood pressure.
These effects are uncommon with properly administered ophthalmic doses but may be more concerning in patients with existing heart conditions.
Your healthcare provider may take additional precautions if you have a history of abnormal heart rhythms or other significant cardiovascular problems.
Applying gentle pressure to the inner corner of the eye after administration can help reduce systemic absorption.
Tell your healthcare provider if you have heart disease, abnormal heart rhythms, or other serious cardiovascular conditions before using Mydriacyl.
Seek immediate medical attention if you experience severe chest pain, fainting, or a persistent rapid heartbeat.
Liver and Kidney Problems
Tell your healthcare provider if you have significant liver or kidney disease before using Mydriacyl.
The liver and kidneys help process and remove many substances from the body.
Although Mydriacyl acts mainly within the eyes, a small amount may enter the bloodstream.
Patients with severe medical conditions may require additional consideration when receiving medications that can cause systemic effects.
However, specific dosage adjustments for liver or kidney impairment are not routinely established for Mydriacyl eye drops.
Your eye care professional will consider your overall medical condition, other medications, and the purpose of the examination.
Measures such as punctal occlusion may help reduce the amount of medication entering the bloodstream.
Inform your healthcare provider about any serious liver or kidney condition before receiving Mydriacyl, particularly if you take several other medications.
Precautions for Older Adults
Older adults should use Mydriacyl under appropriate medical supervision.
Age-related changes in eye structure may increase the likelihood of narrow drainage angles in some patients.
This can raise the risk of an increase in intraocular pressure after pupil dilation.
Older adults may also be more sensitive to certain anticholinergic effects, particularly if they take other medications with similar properties.
Possible effects include dry mouth, dizziness, confusion, or an increased heart rate.
However, clinical studies have not established that all older adults experience more side effects from Mydriacyl than younger patients.
Your eye care professional may assess your medical history, medications, and risk of glaucoma before administering the drops.
Older adults should tell their healthcare provider about existing eye conditions, medications, and previous reactions to pupil-dilating drops before using Mydriacyl.
Use of Mydriacyl in Infants and Young Children
Mydriacyl may be used in children when an eye care professional determines that pupil dilation or cycloplegia is necessary.
However, infants and young children can be particularly sensitive to anticholinergic medications.
Because of their smaller body size, medication absorbed into the bloodstream may produce more noticeable systemic effects.
Possible reactions include flushing, dry mouth, unusual agitation, changes in behavior, rapid heartbeat, or central nervous system disturbances.
In rare cases, serious reactions involving breathing or circulation have been reported with anticholinergic eye medications.
Special care is required when Mydriacyl is used in premature infants, very young children, or children with certain neurological conditions.
Under Canadian prescribing information, Mydriacyl 1% should not be used in infants younger than three months. The original statement about all children under three years is not a general contraindication.
Your healthcare provider will select the appropriate concentration and dosage based on the child’s age and examination needs.
Parents and caregivers should prevent the medication from entering the child’s mouth and wash their own hands and the child’s hands after administration.
Mydriacyl should only be administered to infants and young children under appropriate medical supervision, with careful attention to dosage and signs of systemic side effects.
Important Safety Reminders When Using Mydriacyl
Mydriacyl is used to temporarily enlarge the pupils and relax the eye’s focusing muscles during diagnostic examinations.
Most effects are temporary, including blurred vision and sensitivity to light.
However, certain patients may be more vulnerable to complications, particularly those with narrow-angle glaucoma or increased sensitivity to anticholinergic medications.
Remove contact lenses before administration and avoid driving until your vision returns to normal.
Tell your eye care professional about your medical conditions, medications, and previous allergic reactions.
Seek emergency medical attention if you experience sudden severe eye pain, significant vision loss, difficulty breathing, or severe confusion after using Mydriacyl.
Follow your healthcare provider’s instructions carefully to help ensure that your eye examination is performed safely.
REVIEWS